Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium Respimat in mild persistent asthma
2010-023112-14Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tiotropium in asthma (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Trough forced expiratory volume in one second response at week 12 and Forced expiratory volume in one second. Started Feb 2011; status: completed.
02
Drugs
tiotropium
03
Conditions
asthma
Beyond the preview
Go deeper on 2010-023112-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023112-14.